Literature DB >> 1550420

A brief overview of the pathogenesis of scleroderma (systemic sclerosis).

E C LeRoy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1550420      PMCID： PMC1005679          DOI： 10.1136/ard.51.2.286

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  24 in total

Review 1.  Structure and function of laminin: anatomy of a multidomain glycoprotein.

Authors:  K Beck; I Hunter; J Engel
Journal:  FASEB J       Date:  1990-02-01       Impact factor: 5.191

2.  Tenascin, an extracellular matrix protein, exerts immunomodulatory activities.

Authors:  C R Rüegg; R Chiquet-Ehrismann; S S Alkan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Mitogenic effect of transforming growth factor beta 1 on human fibroblasts involves the induction of platelet-derived growth factor alpha receptors.

Authors:  O Ishikawa; E C LeRoy; M Trojanowska
Journal:  J Cell Physiol       Date:  1990-10       Impact factor: 6.384

4.  Regulated expression and binding of three VLA (beta 1) integrin receptors on T cells.

Authors:  Y Shimizu; G A Van Seventer; K J Horgan; S Shaw
Journal:  Nature       Date:  1990-05-17       Impact factor: 49.962

5.  Increased interleukin-2 production in response to human type I collagen stimulation in patients with systemic sclerosis.

Authors:  E Hawrylko; A Spertus; C A Mele; N Oster; M Frieri
Journal:  Arthritis Rheum       Date:  1991-05

6.  Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.

Authors:  M B Kahaleh; I Osborn; E C LeRoy
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

7.  Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin.

Authors:  Y Shimizu; G A van Seventer; K J Horgan; S Shaw
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

8.  Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex.

Authors:  T Matsuyama; A Yamada; J Kay; K M Yamada; S K Akiyama; S F Schlossman; C Morimoto
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

9.  Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin.

Authors:  E A Wayner; A Garcia-Pardo; M J Humphries; J A McDonald; W G Carter
Journal:  J Cell Biol       Date:  1989-09       Impact factor: 10.539

10.  Connective tissue synthesis by scleroderma skin fibroblasts in cell culture.

Authors:  E C Leroy
Journal:  J Exp Med       Date:  1972-06-01       Impact factor: 14.307
View more
  13 in total

1.  Serum levels of soluble CD21 in patients with systemic sclerosis.

Authors:  Manabu Tomita; Takafumi Kadono; Norihito Yazawa; Tomohiko Kawashima; Zenshiro Tamaki; Ryuichi Ashida; Hanako Ohmatsu; Yoshihide Asano; Makoto Sugaya; Masahide Kubo; Hironobu Ihn; Kunihiko Tamaki; Shinichi Sato
Journal:  Rheumatol Int       Date:  2010-10-30       Impact factor: 2.631

Review 2.  Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis.

Authors:  A L Herrick; S Clark
Journal:  Ann Rheum Dis       Date:  1998-02       Impact factor: 19.103

3.  Systemic sclerosis stimulates angiogenesis in the chick embryo chorioallantoic membrane.

Authors:  D Ribatti; F P Cantatore; A Vacca; M D'Amore; R Ria; L Roncali; V Pipitone
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

4.  Increased capillary permeability in systemic sclerosis: help or hindrance?

Authors:  W Grassi; P Core; C Cervini
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

5.  Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis.

Authors:  H Ihn; K Yamane; N Yazawa; M Kubo; M Fujimoto; S Sato; K Kikuchi; K Tamaki
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

6.  Deficient Smad7 expression: a putative molecular defect in scleroderma.

Authors:  Chunming Dong; Shoukang Zhu; Tao Wang; Woohyun Yoon; Zhiru Li; Rene J Alvarez; Peter ten Dijke; Barbara White; Fredrick M Wigley; Pascal J Goldschmidt-Clermont
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

7.  [Treatment of therapy-resistant acral ulcers with iloprost].

Authors:  S von Schmiedeberg; S Artik; T Assmann; M Megahed; T Ruzicka
Journal:  Hautarzt       Date:  2004-12       Impact factor: 0.751

8.  A nuclear target for interleukin-1alpha: interaction with the growth suppressor necdin modulates proliferation and collagen expression.

Authors:  Bo Hu; Shuhui Wang; Yingze Zhang; Carol A Feghali; Jeffrey R Dingman; Timothy M Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-11       Impact factor: 11.205

9.  Increased frequency of in vivo hprt gene-mutated T cells in the peripheral blood of patients with systemic sclerosis.

Authors:  P P Sfikakis; J Tesar; S Theocharis; G L Klipple; G C Tsokos
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

10.  Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma.

Authors:  B Eckes; C Mauch; G Hüppe; T Krieg
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.